Top compounds associated with response to C5orf63


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA lovastatin CTRPv2 pan-cancer AAC -0.095 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.09 0.01
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.084 0.01
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.01
mRNA AMG-706 GDSC1000 pan-cancer AAC -0.089 0.02
mRNA PD-0325901 CCLE pan-cancer AAC 0.11 0.02
mRNA BRD8958 CTRPv2 pan-cancer AAC 0.096 0.02
mRNA Doxorubicin gCSI pan-cancer AAC -0.12 0.02
Download CSV